23-27 July 2018

22nd International AIDS Conference (AIDS 2018)

The global health community has committed to reaching ten million more people with HIV treatment by 2020. At the 22nd International AIDS Conference (AIDS 2018), taking place 23-27 July, the world’s experts will discuss ways to intensify the response to reach all population groups, particularly those who are stigmatized or have little access to health care facilities.

Unitaid wants to break the back of the HIV epidemic by making the best prevention, diagnostic and treatment solutions available to millions of underserved people. At AIDS 2018, it will share insights from current investments and present new initiatives aimed at turning the tide of the global HIV epidemic.

Don’t miss us at #AIDS2018:


Unitaid’s work in HIV:


For more information on the conference, please visit its official website: www.aids2018.org

Share on Twitter

News and Press Releases

Jul 24, 2018

Global partners pledge over $1.2 billion to launch the MenStar Coalition

Read More

Jul 25, 2018

“MTV SHUGA” launches three new campaigns in South Africa and Côte d’Ivoire, focusing on HIV prevention and self-testing

Read More


Dolutegravir, a better treatment for HIV

In 2015, the World Health Organization recommended dolutegravir as an alternative first-line treatment for adults and adolescents.
It has become a drug of choice for people living with HIV in high-income countries as it has very few side effects.
Unitaid investments are helping to increase access to affordable dolutegravir in less affluent countries.

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.